Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Effect of TIM-3 knockout in the tumoroginesis in the NP53 DMG cell line

ABSTRACT: Effect of TIM-3 knockout in the tumoroginesis in the NP53 DMG cell line

PROVIDER: PRJNA928687 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR23253173_1.fastq.gz	Fastqsanger.gz
	SRR23253173_2.fastq.gz	Fastqsanger.gz
	SRR23253174_1.fastq.gz	Fastqsanger.gz
	SRR23253174_2.fastq.gz	Fastqsanger.gz
	SRR23253175_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 18

Similar Datasets

Effect of TIM-3 knockout in the tumoroginesis in the NP53 DMG cell line

Project description:To investigate the function of TIM-3 expression in the regulation of NP53 proliferation and tumorigenesis differentiation, we established DMG cell lines in which each target gene has been knocked out by CRISPR/Cas9.

2023-12-07 | GSE223859 | GEO

Effect of FAM50 knockout on the transcriptome

Project description:A knockout clone has been generated for both FAM50A and FAM50B; knockout of the other gene is then performed and the transcriptome is analysed to look at the effect of dual gene loss.

| EGAS00001004836 | EGA

Microarray analysis of the effect of shRNA-mediated HAVCR2 knock-down (KD) in TIM-3-positive AML cell line, KASUMI-3

Project description:Purpose: To clarify the function of TIM-3 signaling in AML cells. Analysis of lentiviral shRNA-mediated knockdown of TIM-3 in TIM-3+ acute myeloid leukemia (AML) cell line, KASUMI-3. Consistent with our previous study (Kikushige et al., Cell Stem Cell 2015) revealing the presence of TIM-3/galectin-9 autocrine loop and its constitutive signaling in AML, KD of receptor,TIM-3, alone significantly impaired the proliferation of KASUMI-3 in vitro and in vivo.

2019-04-26 | GSE130328 | GEO

DMG H3-K27M MAPK-altered methylation data

Project description:Diffuse midline gliomas (DMG) are aggressive tumors with a poor prognosis. In this study, a technique called t-SNE analysis was used to cluster tumors based on their methylation profiles. DMG subtype with a co-occurrence of H3.3K27M and BRAF or FGFR1 mutations have been identified. This subtype has a more favorable prognosis, with a median overall survival of 3 years.

2024-07-30 | E-MTAB-13471 | biostudies-arrayexpress

Generation of Syngeneic Orthotopic DMG Murine Models

Project description:Diffuse Midline Glioma (DMG) syngeneic orthotopic murine mouse models were used as high fidelity model of human DMG tumors as they recapitulate the heterogeneity, cell states and OncoTarget/OncoTreat drug predictions of human DMG tumors.

2025-12-22 | GSE262774 | GEO

The effect of TIM-3 stimulation on the gene expression profile of B16-F10 melanoma cells

Project description:The effect of TIM-3 stimulation was studied on B16F10 mouse melanoma cells, in vitro.

2009-10-01 | GSE14418 | GEO

Effect of Rgnef knockout in an aggressive ovarian cancer cell line

Project description:Effect of Rgnef knockout in an aggressive ovarian cancer cell line

| PRJNA522374 | ENA

Inducible Avp Knockout Mouse Line

Project description:Inducible Avp Knockout Mouse Line

| PRJNA1301625 | ENA

microRNA expression in Tim-3 knockdown RAW264.7 cell

Project description:RAW264.7 cell was stably transfected with Tim-3 siRNA(SI) or negative control(NC) and were analyzed for microRNA expression Differerently expressed microRNA in Tim-3 knockdown RAW264.7 cells were summarized and were used for further analysis RAW264.7 cells stably transfected with Tim-3 siRNA(SI) or negative control(NC) and were used to collect microRNA without any other treatment

2016-01-14 | E-GEOD-76839 | biostudies-arrayexpress

Histone H3 wild-type DIPG/DMG overexpressing EZHIP extend the spectrum diffuse midline gliomas with PRC2 inhibition beyond H3-K27M mutation

Project description:Characterisation of a new subgroup of DMG lacking H3-K27M mutation that is defined by H3K27me3 loss and EZHIP overexpression that can be detected by IHC. These tumors are distinct from EZHIP-positive posterior fossa ependymomas and are associated with a dismal prognosis. We propose that these EZHIP/H3-WT tumors need to be considered similar to canonical DIPG/DMG, thus extending the spectrum of DMG with PRC2 inhibition beyond H3-K27M mutation

2020-03-20 | E-MTAB-8888 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data